En una época donde los libros eran escasos y las noticias un lujo, los eruditos se devanaban en disquisiciones, mientras la plebe subsistía a base de cocinas rudimentarias y tradición, los n ...

"Es la santísima trinidad de la corrupción. Señores que no buscan enriquecerse  y que van a por lo mismo: el peluco, el cochazo, el chaletazo y usar a mujeres prostituidas", ha dicho.

Shares of Senores Pharmaceuticals Limited made a healthy debut on the exchange to list at a 53.45% premium. The scrip listed Rs 593.70 per share on BSE, a premium of 51.84% and Rs 600 per share on NSE ...

Wholly Owned Subsidiary of Clean Science and Technology Limited has commenced commercial production of 2,5-Dihydroxy-1,4-Dithiane in a dedicated production block today, 30th December, 2024. The ...

Here is how the category-wise Senores Pharma IPO fared: Non-Institutional Investors: 96.30 times subscribed to 22,33,98,732 shares against 23,19,879 shares allocated for them Qualified Institutional ...

Senores Pharma's IPO was booked 77.64 times at the last count with bids for 66,26,66,458 shares against 85,34,681 shares, led by Non-Institutional Investors (NIIs), and Retail Individual Investors ...

Repasamos lo mejor del año 2024 en cine y series. Como viene siendo habitual, José María Aresté, Pablo de Santiago y Juan Luis Sánchez recomiendan una película reciente, una serie y un clásico.

Mumbai: Bengaluru-based Unimech Aerospace and Manufacturing and Ahmedabad-based Senores Pharmaceuticals have announced initial public offerings (IPOs) collectively worth over ₹1,000 crore ...

The initial public offering (IPO) of Senores Pharmaceuticals opens for bidding on Friday, December 20, while the issue will close for subscription on Tuesday, December 24. The company shall be ...

New Delhi, Dec 18 (PTI) Senores Pharmaceuticals Ltd on Wednesday said it has fixed a price band of Rs 372-391 per share for its Rs 582-crore initial public offering (IPO) that opens for subscription ...

Senores Pharmaceuticals Ltd. will launch its initial public offering on Dec. 20 at a price band of Rs 372 to Rs 391 per share. The Ahmedabad-based pharmaceutical firm's IPO will comprise of a fresh ...